HumaninMitochondrial peptide · research
Humanin is a small peptide studied for its role in cellular stress responses. Laboratory findings are intriguing, but they do not yet tell us whether giving humanin to people improves health or extends life.
What is Humanin?
Humanin is a small peptide associated with mitochondrial biology. It is studied in cell-survival, metabolic-stress and neurodegeneration research.
How it works
Experimental work links humanin to cell-survival pathways and metabolic regulation. These mechanisms are investigated in cellular and other experimental systems, rather than established as longevity treatments.
Effects studied
Promising findings differed between species
A 2020 study found that humanin overexpression extended lifespan in C. elegans worms. In mice treated with the HNG humanin analogue, researchers reported metabolic and inflammatory changes, but the survival analysis did not show a significant lifespan difference. That leaves a worthwhile healthspan hypothesis while keeping worm longevity, mouse findings and human treatment claims separate. HNG is a modified analogue, not interchangeable with every humanin product. 1
Evidence: Species-specific experimental findings; no significant mouse lifespan difference.
An intriguing observation in families
The same paper found higher circulating humanin in children of centenarians than in age-matched controls. That association is interesting because it connects the laboratory question with human longevity. It does not show that giving humanin reproduces the families’ health or longevity: inherited traits, environment and other biological differences can contribute. No human treatment benefit follows directly from this comparison. 1
Evidence: Human association; not a supplementation trial.
What does the evidence show?
Laboratory, animal and observational research
Why researchers study humanin
Humanin belongs to a group of peptides associated with mitochondrial biology. Mitochondria help cells manage energy, but they also participate in signalling. Researchers have investigated whether humanin helps cells cope with injury, metabolic stress and processes associated with neurodegeneration.
Promising findings differed between species
A 2020 study found that humanin overexpression extended lifespan in C. elegans worms. In mice treated with the HNG humanin analogue, researchers reported metabolic and inflammatory changes, but the survival analysis did not show a significant lifespan difference. That leaves a worthwhile healthspan hypothesis while keeping worm longevity, mouse findings and human treatment claims separate. HNG is a modified analogue, not interchangeable with every humanin product. 1
An intriguing observation in families
The same paper found higher circulating humanin in children of centenarians than in age-matched controls. That association is interesting because it connects the laboratory question with human longevity. It does not show that giving humanin reproduces the families’ health or longevity: inherited traits, environment and other biological differences can contribute. No human treatment benefit follows directly from this comparison. 1
What human treatment studies would need to show
A useful treatment study would need a well-characterised preparation, meaningful health outcomes and adequate follow-up for adverse effects. The archived research does not establish those requirements for routine longevity use. Modified humanin analogues also need their own assessment; a result with one sequence should not be attributed automatically to every product carrying the name.
Safety & status
A human treatment safety profile requires a defined preparation and adequate follow-up. Modified humanin analogues need separate evaluation; their effects cannot be assumed to match the original peptide.
Country and product status
Product indications and availability vary by country; current EU and Swiss status has not been independently checked for this draft.
Frequently asked questions
Do low humanin levels mean supplementation would help?
An association between a biomarker and disease does not show that raising the biomarker reverses the disease.
Are humanin analogues interchangeable?
No. A changed sequence is a different preparation whose activity and safety need separate study.
Further reading
Sources
This entry was rewritten from our research archive. References below are reading leads unless a completed check is explicitly noted; a full independent evidence and regulatory review is still pending.
- Yen et al. (2020): Humanin is a regulator of lifespan and healthspan Primary animal intervention and human association research · PubMed abstract and figure captions checked, including mouse survival panel; full methods not reviewed; checked 2026-10-29
Research provenance
This name was discovered in the Superpower peptide index, archived 26 October 2026. Its ratings and reviewer attribution have not been adopted as our own. The archive informed this original editorial draft; independent source review is still pending.